EPISODE · Aug 6, 2026 · 3 MIN
Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA
from Neurology Minute · host American Academy of Neurology
Dr. Elizabeth Coon and Dr. Lucy Norcliffe-Kaufmann discuss the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent clinical trial results and future directions. Show citation: Freeman R, Kaufmann H, Biaggioni I, et al. Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Randomized Withdrawal Trial. Neurology. 2026;107(3):e218284. doi:10.1212/WNL.0000000000218284
Embed this episode
Ready to play
Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA
No transcript for this episode yet
Similar Episodes
No similar episodes found.